Paper28293038
Naphthacemycins, novel circumventors of β-lactam resistance in MRSA, produced by Streptomyces sp. KB-3346-5. I. The taxonomy of the producing strain, and the fermentation, isolation and antibacterial activities.
Fukumoto A and 11 others. J Antibiot (Tokyo), 2017. Cited by 24 papers, by iCite.
Cite this record
ConductScience Library. Naphthacemycins, novel circumventors of β-lactam resistance in MRSA, produced by Streptomyces sp. KB-3346-5. I. The taxonomy of the producing strain, and the fermentation, isolation and antibacterial activities. Papers, record 28293038. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28293038
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Naphthacemycins, novel circumventors of β-lactam resistance in MRSA, produced by Streptomyces sp. KB-3346-5. I. The taxonomy of the producing strain, and the fermentation, isolation and antibacterial activities.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Imipenem | Major topic |
| Methicillin-Resistant Staphylococcus aureus | Major topic |
| Streptomyces | Major topic |
| Chromatography, High Pressure Liquid | |
| Drug Design | |
| Drug Synergism | |
| Microbial Sensitivity Tests | |
| beta-Lactam Resistance | |
| beta-Lactams |
Source PubMed
References16
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11347972 | Microbial fermentation-derived inhibitors of efflux-pump-mediated drug resistance. | Farmaco | 2001 | https://conductscience.org/library/papers/11347972 | PubMed |
| 2 | 485765 | [Metabolic products of microorganisms. 175. Tetracenomycin C (author's transl)]. | Arch Microbiol | 1979 | https://conductscience.org/library/papers/485765 | PubMed |
| 3 | 18305353 | Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Streptomyces sp. K04-0144. II. Biological activities. | J Antibiot (Tokyo) | 2008 | https://conductscience.org/library/papers/18305353 | PubMed |
| 4 | 18936894 | Final report from the Committee on Antimicrobial Susceptibility Testing, Japanese Society of Chemotherapy, on the agar dilution method (2007). | J Infect Chemother | 2008 | https://conductscience.org/library/papers/18936894 | PubMed |
| 5 | 15516341 | Determination of selectivity and efficacy of fatty acid synthesis inhibitors. | J Biol Chem | 2005 | https://conductscience.org/library/papers/15516341 | PubMed |
| 6 | 21768346 | Functional analysis of environmental DNA-derived type II polyketide synthases reveals structurally diverse secondary metabolites. | Proc Natl Acad Sci U S A | 2011 | https://conductscience.org/library/papers/21768346 | PubMed |
| 7 | 28293036 | Naphthacemycins, novel circumventors of β-lactam resistance in MRSA, produced by Streptomyces sp. KB-3346-5. II. Structure elucidation. | J Antibiot (Tokyo) | 2017 | https://conductscience.org/library/papers/28293036 | PubMed |
| 8 | 18585915 | The role of virulence determinants in community-associated MRSA pathogenesis. | Trends Microbiol | 2008 | https://conductscience.org/library/papers/18585915 | PubMed |
| 9 | 8031024 | Tetracycline analogs whose primary target is not the bacterial ribosome. | Antimicrob Agents Chemother | 1994 | https://conductscience.org/library/papers/8031024 | PubMed |
| 10 | 22224500 | Environmental DNA-encoded antibiotics fasamycins A and B inhibit FabF in type II fatty acid biosynthesis. | J Am Chem Soc | 2012 | https://conductscience.org/library/papers/22224500 | PubMed |
| 11 | 894261 | Distribution of menaquinones in actinomycetes and corynebacteria. | J Gen Microbiol | 1977 | https://conductscience.org/library/papers/894261 | PubMed |
| 12 | 18305352 | Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Streptomyces sp. K04-0144. I. Taxonomy, fermentation, isolation and structural elucidation. | J Antibiot (Tokyo) | 2008 | https://conductscience.org/library/papers/18305352 | PubMed |
| 13 | 19862477 | The tetracycline resistome. | Cell Mol Life Sci | 2010 | https://conductscience.org/library/papers/19862477 | PubMed |
| 14 | 23157252 | Tetarimycin A, an MRSA-active antibiotic identified through induced expression of environmental DNA gene clusters. | J Am Chem Soc | 2012 | https://conductscience.org/library/papers/23157252 | PubMed |
| 15 | 16180833 | Anthrabenzoxocinones from Streptomyces sp. as liver X receptor ligands and antibacterial agents. | J Nat Prod | 2005 | https://conductscience.org/library/papers/16180833 | PubMed |
| 16 | 1429222 | Benastatins A and B, new inhibitors of glutathione S-transferase, produced by Streptomyces sp. MI384-DF12. I. Taxonomy, production, isolation, physico-chemical properties and biological activities. | J Antibiot (Tokyo) | 1992 | https://conductscience.org/library/papers/1429222 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41988676 | Using X-ray Crystallography and 1,n-ADEQUATE NMR to Revise the Structures of Highly Substituted Aromatic Natural Products: The Absolute Configuration of Formicamycin Congeners. | J Nat Prod | 2026 | https://conductscience.org/library/papers/41988676 | PubMed |
| 40104604 | Mangrove pneumatophores as biocatalysts for the fabrication of silver nanoparticles and their potential applications against biofilm formation and hepatic carcinoma. | Nanoscale Adv | 2025 | https://conductscience.org/library/papers/40104604 | PubMed |
| 39265189 | Total Synthesis of the Phenylnaphthacenoid Type II Polyketide Antibiotic Formicamycin H via Regioselective Ruthenium-Catalyzed Hydrogen Auto-Transfer [4 + 2] Cycloaddition. | J Am Chem Soc | 2024 | https://conductscience.org/library/papers/39265189 | PubMed |
| 37327570 | Heterologous Expression of the Formicamycin Biosynthetic Gene Cluster Unveils Glycosylated Fasamycin Congeners. | J Nat Prod | 2023 | https://conductscience.org/library/papers/37327570 | PubMed |
| 33092156 | Discovery of New Antibacterial Accramycins from a Genetic Variant of the Soil Bacterium, Streptomyces sp. MA37. | Biomolecules | 2020 | https://conductscience.org/library/papers/33092156 | PubMed |
| 32422934 | Mersaquinone, A New Tetracene Derivative from the Marine-Derived Streptomyces sp. EG1 Exhibiting Activity against Methicillin-Resistant Staphylococcus aureus (MRSA). | Antibiotics (Basel) | 2020 | https://conductscience.org/library/papers/32422934 | PubMed |
| 31533358 | Accramycin A, a New Aromatic Polyketide, from the Soil Bacterium, Streptomyces sp. MA37. | Molecules | 2019 | https://conductscience.org/library/papers/31533358 | PubMed |
| 28293036 | Naphthacemycins, novel circumventors of β-lactam resistance in MRSA, produced by Streptomyces sp. KB-3346-5. II. Structure elucidation. | J Antibiot (Tokyo) | 2017 | https://conductscience.org/library/papers/28293036 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28293038
GET https://conductscience.org/api/papers/v1/28293038/authors